<DOC>
	<DOC>NCT02149641</DOC>
	<brief_summary>In the treatment of nasopharyngeal cancers, to determine the incidence of high grade (≥G2) subjective xerostomia at 1 year.</brief_summary>
	<brief_title>Parotid-sparing IMRT for Nasopharyngeal Cancer</brief_title>
	<detailed_description>The purpose of this study was to determine the feasibility in delivering induction chemotherapy and concomitant chemotherapy with IMRT in the treatment of locally advanced nasopharyngeal cancers and to determine the incidence of high grade (≥G2) subjective xerostomia at 1 year.</detailed_description>
	<mesh_term>Nasopharyngeal Neoplasms</mesh_term>
	<criteria>nasopharyngeal cancers Patients &lt;16 years old or with a previous malignancy other than nonmelanomatous skin cancer were excluded</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>